Report overview
This report contains market size and forecasts of Passive Transdermal Drug Delivery in global, including the following market information:
Global Passive Transdermal Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Passive Transdermal Drug Delivery Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Passive Transdermal Drug Delivery companies in 2021 (%)
The global Passive Transdermal Drug Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Microfluidics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Passive Transdermal Drug Delivery include 3M, Actavis, Inc., Bayer AG, Boehringer Ingelheim GmbH, Corium International, Inc., Echo Therapeutics, Inc., GlaxoSmithKline plc, Johnson & Johnson (Janssen Pharmaceuticals Inc.) and Mylan N.V., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Passive Transdermal Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Passive Transdermal Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Passive Transdermal Drug Delivery Market Segment Percentages, by Type, 2021 (%)
Microfluidics
Smart Pill Technology (SPT)
Global Passive Transdermal Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Passive Transdermal Drug Delivery Market Segment Percentages, by Application, 2021 (%)
Clinic
Hospital
Others
Global Passive Transdermal Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Passive Transdermal Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Passive Transdermal Drug Delivery revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Passive Transdermal Drug Delivery revenues share in global market, 2021 (%)
Key companies Passive Transdermal Drug Delivery sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Passive Transdermal Drug Delivery sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.
